^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

XY123

i
Other names: XY123
News
Trials
Company:
Chinese Academy of Medical Sciences
Drug class:
RORγ inverse agonist
News
Trials